Terms: = Germ cell tumor AND SDHD, PGL1, 6392, ENSG00000204370, PGL, SDH4, CBT1, O14521 AND Prognosis
42 results:
1. Ectopic pheochromocytomas in the third trimester: A case report and literature review.
Zhao L; Chen M; Chen X; Yu L; Du SG; Gan Q; Yang WZ; Jiang C; Xiao M
Medicine (Baltimore); 2024 Feb; 103(5):e36127. PubMed ID: 38306535
[TBL] [Abstract] [Full Text] [Related]
2. Tumour microenvironment in pheochromocytoma and paraganglioma.
Martinelli S; Amore F; Canu L; Maggi M; Rapizzi E
Front Endocrinol (Lausanne); 2023; 14():1137456. PubMed ID: 37033265
[TBL] [Abstract] [Full Text] [Related]
3. SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis.
Su T; Yang Y; Jiang L; Xie J; Zhong X; Wu L; Jiang Y; Zhang C; Zhou W; Ye L; Ning G; Wang W
Front Endocrinol (Lausanne); 2023; 14():1121397. PubMed ID: 37008946
[TBL] [Abstract] [Full Text] [Related]
4. Bladder paraganglioma: basic characteristics and new perspectives on perioperative management.
Cai T; Lu J; Lin Z; Luo M; Liang H; Qin Z; Ye Y
World J Urol; 2022 Nov; 40(11):2807-2816. PubMed ID: 36205740
[TBL] [Abstract] [Full Text] [Related]
5. Colorectal paragangliomas with immunohistochemical deficiency of succinate dehydrogenase subunit B.
Kimura N; Ishikawa M; Shigematsu K
Endocr J; 2022 May; 69(5):523-528. PubMed ID: 34853215
[TBL] [Abstract] [Full Text] [Related]
6. [Endocrine and neuroendocrine tumors].
Riss P; Scheuba K; Strobel O
Chirurg; 2021 Nov; 92(11):996-1002. PubMed ID: 34618164
[TBL] [Abstract] [Full Text] [Related]
7. LncRNA expression and SDHB mutations in pheochromocytomas and paragangliomas.
Li H; Hardin H; Zaeem M; Huang W; Hu R; Lloyd RV
Ann Diagn Pathol; 2021 Dec; 55():151801. PubMed ID: 34461576
[TBL] [Abstract] [Full Text] [Related]
8. Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience.
De Filpo G; Cantini G; Rastrelli G; Vannini G; Ercolino T; Luconi M; Mannelli M; Maggi M; Canu L
J Endocrinol Invest; 2022 Jan; 45(1):149-157. PubMed ID: 34227051
[TBL] [Abstract] [Full Text] [Related]
9. Succinate Mediates tumorigenic Effects
Matlac DM; Hadrava Vanova K; Bechmann N; Richter S; Folberth J; Ghayee HK; Ge GB; Abunimer L; Wesley R; Aherrahrou R; Dona M; Martínez-Montes ÁM; Calsina B; Merino MJ; Schwaninger M; Deen PMT; Zhuang Z; Neuzil J; Pacak K; Lehnert H; Fliedner SMJ
Front Endocrinol (Lausanne); 2021; 12():589451. PubMed ID: 33776908
[TBL] [Abstract] [Full Text] [Related]
10. The emerging clinical relevance of genomic profiling in neuroendocrine tumours.
Burak GI; Ozge S; Cem M; Gulgun B; Zeynep DY; Atil B
BMC Cancer; 2021 Mar; 21(1):234. PubMed ID: 33676450
[TBL] [Abstract] [Full Text] [Related]
11. Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea.
Park H; Kim MS; Lee J; Kim JH; Jeong BC; Lee S; Lee SK; Cho SY; Jin DK
Front Endocrinol (Lausanne); 2020; 11():610746. PubMed ID: 33584544
[TBL] [Abstract] [Full Text] [Related]
12. Characteristics of germline mutations in Korean patients with pheochromocytoma/paraganglioma.
Kim JH; Kim MJ; Kong SH; Kim SJ; Kang H; Shin CS; Park SS; Lee KE; Seong MW
J Med Genet; 2022 Jan; 59(1):56-64. PubMed ID: 33219105
[TBL] [Abstract] [Full Text] [Related]
13. Epigenetic and metabolic reprogramming of SDH-deficient paragangliomas.
Moog S; Lussey-Lepoutre C; Favier J
Endocr Relat Cancer; 2020 Dec; 27(12):R451-R463. PubMed ID: 33112834
[TBL] [Abstract] [Full Text] [Related]
14. New Insights into Pheochromocytoma Biology: the Role of the Insulin - Like Growth Factor 1 (IGF1) System.
Pennisi PA; Fernández MC; Martin A
Pediatr Endocrinol Rev; 2020 Aug; 17(4):331-342. PubMed ID: 32780957
[TBL] [Abstract] [Full Text] [Related]
15. Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents.
Jochmanova I; Abcede AMT; Guerrero RJS; Malong CLP; Wesley R; Huynh T; Gonzales MK; Wolf KI; Jha A; Knue M; Prodanov T; Nilubol N; Mercado-Asis LB; Stratakis CA; Pacak K
J Cancer Res Clin Oncol; 2020 Apr; 146(4):1051-1063. PubMed ID: 32062700
[TBL] [Abstract] [Full Text] [Related]
16. tumor-specific prognosis of mutation-positive patients with head and neck paragangliomas.
Sen I; Young WF; Kasperbauer JL; Polonis K; Harmsen WS; Colglazier JJ; DeMartino RR; Oderich GS; Kalra M; Bower TC
J Vasc Surg; 2020 May; 71(5):1602-1612.e2. PubMed ID: 32035780
[TBL] [Abstract] [Full Text] [Related]
17. SDHx-related pheochromocytoma/paraganglioma - genetic, clinical, and treatment outcomes in a series of 30 patients from a single center.
Donato S; Simões H; Pinto AT; M Cavaco B; Leite V
Endocrine; 2019 Aug; 65(2):408-415. PubMed ID: 31104306
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic Factors of Malignant Pheochromocytoma and Paraganglioma: A Combined SEER and TCGA Databases Review.
Mei L; Khurana A; Al-Juhaishi T; Faber A; Celi F; Smith S; Boikos S
Horm Metab Res; 2019 Jul; 51(7):451-457. PubMed ID: 30919391
[TBL] [Abstract] [Full Text] [Related]
19. Nonmosaic somatic HIF2A mutations associated with late onset polycythemia-paraganglioma syndrome: Newly recognized subclass of polycythemia-paraganglioma syndrome.
Pang Y; Gupta G; Jha A; Yue X; Wang H; Huynh TT; Li A; Li L; Baker E; Chew E; Feelders RA; Korpershoek E; Zhuang Z; Yang C; Pacak K
Cancer; 2019 Apr; 125(8):1258-1266. PubMed ID: 30644531
[TBL] [Abstract] [Full Text] [Related]
20. Paraganglioma with a very rare presentation.
Khare M; Gupta MK; Sharma UB; Garg KM
Indian J Pathol Microbiol; 2018; 61(3):404-406. PubMed ID: 30004066
[TBL] [Abstract] [Full Text] [Related]
[Next]
